We have previously demonstrated that tumors depleted of VDAC1 undergo metabolic reprograming (Figure 1), leading to a reduction of tumor growth, invasiveness, and angiogenesis, and the disappearance of cancer stem cells, while inducing tumor cell differentiation [49]. The gene discussed is VDAC1; the disease is cancer.